Acurx Pharmaceuticals, Inc.ACXPNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
Year-over-Year Change
Price-to-earnings ratio
Latest
-0.98
↑ 85% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthElevated
Average
-6.39
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2024 | -0.98 | +70.5% |
| 2023 | -3.33 | +6.5% |
| 2022 | -3.56 | -2.8% |
| 2021 | -3.46 | +79.6% |
| 2020 | -17.01 | -70.4% |
| 2019 | -9.98 | - |